Alcansado, Jenny .

HRN: 13-73-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2025
CEFUROXIME 500MG (TAB)
09/15/2025
09/21/2025
ORAL
500mg
BID
Repeat CS With BTL
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominalReproductive Tract    Compliance to guidelines: Compliant To Guidelines